Using neuroimaging to evaluate and guide pharmacological and psychotherapeutic treatments for mood disorders in children

Manpreet K. Singh, Amy S Garrett, Kiki D. Chang

Resultado de la investigación: Review articlerevisión exhaustiva

3 Citas (Scopus)

Resumen

Mood disorders are increasing in childhood, and often require multimodal and comprehensive treatment plans to address a complex array of symptoms and associated morbidities. Pharmacotherapy, in combination with psychotherapeutic interventions, is essential for treatment and stabilization. Current evidence supports the use of a number of interventions in children and adolescents diagnosed with DSM-5 mood spectrum disorders, which are associated with impairments in prefrontal-striatal-limbic networks, which are key for emotional functioning and regulation. Yet, little is known about the neurobiological effects of interventions on the developing brain. This chapter provides a synopsis of the literature demonstrating the neural effects of psychotropic medications and psychotherapy in youth with depressive or bipolar spectrum disorders. Additional longitudinal and biological studies are warranted to characterize the effects of these interventions on all phases and stages of mood illness development in children and adolescents.

Idioma originalEnglish (US)
Páginas (desde-hasta)359-368
Número de páginas10
PublicaciónCNS Spectrums
Volumen20
N.º4
DOI
EstadoPublished - ene. 1 2015
Publicado de forma externa

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health

Huella

Profundice en los temas de investigación de 'Using neuroimaging to evaluate and guide pharmacological and psychotherapeutic treatments for mood disorders in children'. En conjunto forman una huella única.

Citar esto